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 CHAPTER 2-2 
MEDICAL USES:  BIOLOGICALLY  
ACTIVE SUBSTANCES 
 
 
Figure 1.  Bryophytes and other herbs on sale in a Yunnan, China, market.  Rhodobryum giganteum (upper bag) and Leucobryum 
(lower bag), both called Hui Xin Cao.  Photo by courtesy of Eric Harris. 
Antibiotics and Other Biologically Active Substances 
Bryophyte species actually produce broad-range 
antibiotics (Asakawa 2007a, b, 2008; Asakawa et al. 2013).  
Their usage in surgical dressings, diapers, and other human 
medicinal applications is well known.  And their use has 
not been confined to Asia (Frahm 2004), but is known in 
Brazil (Pinheiro da Silva et al. 1989), England (Wren 
1956), North America (Pejin et al. 2011a, b), and Germany 
(Frahm 2004), as well as in China (Ding 1982; Wu 1982) 
and India (Watts 1891).  Frahm (2007) has reviewed the 
literature on bryophytes and their antibiotic activity. 
Bryophytes discourage the feeding by a variety of 
organisms, as discussed in the chapters on terrestrial 
insects, arthropods, and other interaction chapters.  Frahm 
and Kirchhoff (2002) showed that extracts of the epiphytic 
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moss Neckera crispa (Figure 2) and leafy liverwort Porella 
obtusata (Figure 3) both discouraged feeding by the 
Portuguese slug Arion lusitanicus (Figure 4). 
 
 
Figure 2.  Neckera crispa, a species that discourages the 
Portuguese slug from eating it.  Photo by Jan-Peter Frahm, with 
permission. 
 
Figure 3.  Porella obtusata, a species that discourages the 
Portuguese slug from eating it.  Photo by Michael Lüth, with 
permission. 
 
Figure 4.  Arion lusitanicus, a slug that avoids eating 
extracts of the moss Neckera crispa and leafy liverwort Porella 
obtusata.  Photo by Ondřej Zicha, through Creative Commons. 
One indication of the presence of unique and 
potentially important pharmaceutically and anti-feedant 
chemicals in bryophytes is the presence of unique odors.  
This is especially true for liverworts, with more than 
several hundred new compounds identified among them 
(Asakawa 2012).  In addition, more than 40 new carbon 
skeletal acetogenins, phenolic compounds, and terpenoids 
were identified.  Testing of these compounds has led to the 
commercial development of a natural pesticide (Frahm 
2004). 
Leptolejeunea (Figure 5) and Moerckia (Figure 6) are 
distinctly aromatic (Schuster 1966), Lophozia bicrenata 
(Figure 7) has a pleasant odor, species of Solenostoma 
(Figure 8) smell like carrots, Geocalyx graveolens (Figure 
9) has a turpentine-like odor, and Conocephalum conicum 
(Figure 10) smells like mushrooms.  The tropical 
Plagiochila rutilans (Figure 11) smells like peppermint, 
caused by several methane monoterpenoids (Heinrichs et 
al. 2001). 
 
 
Figure 5.  Leptolejeunea elliptica, a species with a distinct 
odor.  Photo by Yan Jia-dang, through Creative Commons. 
 
Figure 6.  Moerckia flotoviana female, a species with a 
distinct odor.  Photo by Michael Lüth, with permission. 
 
Figure 7.  The leafy liverwort Lophozia bicrenata.  Photo by 
Michael Lüth. 
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Figure 8.  Solenostoma hyalina, a species that smells like 
carrots.  Photo by Janice Glime. 
 
 
Figure 9.  The leafy liverwort Geocalyx graveolens.  
Underleaf is indicated by the red star.  Photo by Michael Lüth. 
 
 
Figure 10.  Conocephalum conicum, a species that smells 
like mushrooms.  Photo by Hermann Schachner, through Creative 
Commons. 
But can you imagine using mosses to lower your 
cholesterol?  Yes, mosses contain polyunsaturated fatty 
acids that are already known to have important potentials in 
human medicine, such as preventing atherosclerosis and 
cardiovascular disease, reducing collagen-induced 
thrombocyte aggregation, and lowering triacylglycerols and 
cholesterol in plasma (Radwan 1991). 
 
Figure 11.  Plagiochila sp.  Plagiochila rutilans smells like 
peppermint.  Photo by Lin Kyan, with permission. 
It appears that these unique odors result from a 
combination of many compounds, including monoterpene 
hydrocarbons such as α-pinene, ß-pinene, camphene, 
sabinene, myrcene, alpha-terpinene, limonene, fatty acids, 
and methyl esters of low molecular weight (Hayashi et al. 
1977).  For example, Isotachis japonica (Figure 12) has at 
least three aromatic esters:   benzyl benzoate, benzyl 
cinnamate, and B-phenylethyl cinnamate (Matsuo et al. 
1971). 
 
 
Figure 12.  Isotachis sp.  Isotachis japonica has at least three 
aromatic esters.  Photo by George Shepherd, through Creative 
Commons. 
But progress in purifying and identifying bryophyte 
biochemical components and demonstrating their antibiotic 
effects has been slow.  As early as 1952, Madsen and Pates 
found inhibition of microorganisms in products of 
bryophytes, including Sphagnum portoricense (Figure 13), 
S. strictum (Figure 14), Conocephalum conicum (Figure 
10), and Dumortiera hirsuta (Figure 15) (see also 
Sabovljević et al. 2011; Chandra et al. 2017).  Pavletic and 
Stilinovic (1963) found that Dicranum scoparium (Figure 
16) strongly inhibited all bacteria tested but Gram-negative 
Escherichia coli (Figure 17).  McCleary and Walkington 
(1966) considered that non-ionized organic acids and 
polyphenolic compounds might contribute to the antibiotic 
properties of bryophytes and found eighteen mosses that 
strongly inhibited one or both of Gram-positive and Gram-
negative bacteria, the most active being Atrichum (Figure 
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20), Dicranum (Figure 16), Mnium (Figure 18), 
Polytrichum (Figure 19), and Sphagnum.  Reminiscent of 
Dicranum scoparium (Figure 16), Atrichum undulatum 
(Figure 20) was effective on everything tested except 
Enterobacter aerogenes (drug resistant and infectious to 
people with weak immune systems; Figure 21) and E. coli. 
 
 
Figure 13.  Sphagnum portoricense, a species that inhibits 
microorganisms.  Photo by Blanka Shaw, with permission. 
 
 
Figure 14.  Sphagnum strictum, a species that inhibits 
microorganisms.  Photo by Jan-Peter Frahm, with permission. 
 
 
Figure 15.  Dumortiera hirsuta, a species that inhibits 
microorganisms.  Photo by Michael Lüth, with permission. 
 
Figure 16.  Dicranum scoparium, a species that inhibited all 
bacteria tested but Gram-negative Escherichia coli.  Photo by 
Janice Glime. 
 
 
Figure 17.  Escherichia coli, a species that is inhibited by 
acetone-soluble extracts of several thallose liverwort species.  
Photo by NIAID, through Creative Commons. 
 
 
Figure 18.  Mnium spinulosum.  Members of the genus 
Mnium are among the most active against one or both of Gram-
positive and Gram-negative bacteria.  Photo by Michael Lüth, 
with permission. 
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Figure 19.  Polytrichum commune.  Members of the genus 
Polytrichum are among the most active against one or both of 
Gram-positive and Gram-negative bacteria.  Photo by Michael 
Lüth, with permission. 
 
Figure 20.  Atrichum undulatum is a moss that is very 
effective against a wide range of bacteria.  Photo by Michael 
Lüth. 
 
Figure 21.  Enterobacter aerogenes, a bacterium that seems 
to be resistant to extracts of 18 moss species that negatively affect 
other bacteria.  Photo by Alexa Rakusin Muna, through Creative 
Commons. 
Gupta and Singh (1971) found high occurrence of 
antibacterial activity in extracts of Barbula species (Figure 
22), reaching as high as 36.2%, whereas it was only half 
that in Timmiella species (Figure 23) (18.8%).  In 1982, 
Asakawa et al. (1982) isolated three prenyl bibenzyls from 
Radula spp. (Figure 24) and demonstrated that these 
bibenzyls could inhibit growth of Staphylococcus aureus 
(Figure 25) at concentrations of 20.3 µg ml-1.  Out of more 
than 80 species tested, Ichikawa (1982) and coworkers 
(1983) found antimicrobial activity in nearly all.  Acyclic 
acetylenic fatty acid and cyclophentenonyl fatty acid 
extracts from the mosses completely inhibited the growth 
of the rice blast fungus Magnaporthe grisea (Figure 26).  
Belcik and Wiegner (1980) reported antimicrobial activity 
in extracts of the liverworts Pallavicinia (Figure 27) and 
Reboulia (Figure 28), and Isoe (1983) reported it from 
Porella (Figure 29). 
 
 
Figure 22.  Barbula convoluta, member of a genus with high 
antibacterial activity.  Photo by Michael Lüth, with permission. 
 
Figure 23.  Timmiella sp., a genus with high antibacterial 
activity.  Photo by Ken-ichi Ueda through Creative Commons. 
 
Figure 24.  Radula complanata, a species with bibenzyls that 
could inhibit growth of Staphylococcus aureus.  Photo by Michael 
Lüth, with permission. 
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Figure 25.  Staphylococcus aureus, a bacterium that is not 
inhibited by the thallose liverwort Riccia fluitans.  Photo by 
NIAID, through Creative Commons. 
 
 
Figure 26.  Magnaporthe grisea, a plant pest that is inhibited 
by several liverworts.  Photo by IRRI Photos, through Creative 
Commons. 
 
Figure 27.  Pallavicinia lyellii, member of a genus with 
reported antimicrobial activity.  Photo by Jan-Peter Frahm, with 
permission. 
 
Figure 28.  Reboulia hemisphaerica, member of a genus 
with reported antimicrobial activity.  Photo by Malcolm Storey 
<www.discoverlife.org>, with online permission. 
 
 
Figure 29.  Porella platyphylla, member of a genus with 
reported antimicrobial activity.  Photo by Tim Waters through 
Creative Commons. 
Another three species of mosses [Anomodon rostratus 
(Figure 30), Plagiomnium cuspidatum (Figure 31), 
Orthotrichum rupestre (Figure 32)] produce substances 
that inhibit bacteria and fungi, but these inhibitors seem to 
be unstable products that vary considerably among species 
and possibly also among seasons (McCleary et al. 1960).  
Indeed, it would appear that some of these antibiotic 
compounds are the very ones that bryophytes produce in 
response to stress.  However useful they may be, it seems 
that these discoveries have not yet found their way into 
medical practice. 
 
 
Figure 30.  Anomodon rostratus, a species that inhibits 
bacteria and fungi.  Photo by Dale A. Zimmerman Herbarium, 
Western New Mexico University, with permission. 
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Figure 31.  Plagiomnium cuspidatum, a species that inhibits 
bacteria and fungi.  Photo by Štĕpán Koval, with permission. 
 
Figure 32.  Orthotrichum rupestre, a species that inhibits 
bacteria and fungi.  Photo by Michael Lüth, with permission. 
Scientists have found innumerable kinds of biological 
activity in compounds from bryophytes.  Even in a single 
species, one might find multiple kinds of activity.  For 
example, the liverworts Plagiochasma japonica and 
Marchantia emarginata subsp. tosana (Figure 33) exhibit 
antitumor activity, antifungal and antimicrobial activity, 
inhibition of superoxide release, inhibition of thrombin 
activity, and muscle relaxation (Lahlou et al. 2000).  As is 
often the case with herbal medicine, the effect of the total 
extract is better than that of the isolated compounds, 
perhaps due to a synergistic effect (Frahm 2004). 
 
 
Figure 33.  Marchantia emarginata subsp. tosana, a 
subspecies with a wide range of medicinal properties.  Photo by 
Taiwan Mosses, through Creative Commons. 
On the other hand, some researchers claim that 
antibiotic properties of some mosses, including Sphagnum 
(Figure 13, Figure 14), may actually be the work of 
associated microorganisms.  In some cases, e.g. 
Sphagnum, it may be Penicillium sp. (Figure 34) effecting 
this antibiotic ability (Lewington 1990).  Or is it the closely 
associated Cyanobacteria, such as Nostoc (Figure 35) 
(Spjut et al. 1988; Solheim & Zielke 2002)? 
 
 
Figure 34.  Penicillium expansum on pear, in a genus that 
can grow on Sphagnum and may contribute to its antibiotic 
effects.  Photo by H. J. Larsen, through Creative Commons. 
 
 
Figure 35.  Nostoc pruniforme, in a genus with close 
associations with Sphagnum and other bryophytes and could 
contribute to antibiotic properties.  Photo by Lairich Rig, through 
Creative Commons. 
Painter (2003) notes that Sphagnum (Figure 13, Figure 
14) can be 3-4 times as absorbent as cotton equivalents.  
But its call to fame seems to be its ability to react 
chemically with all sorts of proteins.  Sphagnum species 
have the potential to immobilize whole bacterial cells, 
enzymes, exotoxins, and lysins that are secreted by most of 
the invasive pathogens.  Once these are immobilized, they 
are inactivated by a Maillard reaction. 
The Maillard reaction makes this story complex.  It is 
known to suppress the virulence gene expression operon in 
the bacterium Listeria monocytogenes (Figure 36) (Sheikh-
Zeinoddin et al. 2000), so that is a good thing.  On the 
other hand, a variety of foods form potential cancer-causing 
acrylamides, especially fried foods (Stadler et al. 2002).  
Such acrylamides can be released by thermally treating 
certain amino acids such as asparagine, especially in 
combination with reducing sugars through the Maillard 
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reaction.  The early Maillard reaction products are N-
glycosides.  Painter (1998) found that the Maillard reaction 
inhibits microbial growth in animal products preserved in 
bogs by sequestering ammonia, amino acids, and peptides, 
whereas the polymeric end-products (melanoidins) inhibit 
their growth by cross-linking the polypeptide chains and 
sequestering essential multivalent metal cations.  In short, 
the Maillard reaction appears to be an important component 
of the Sphagnum (Figure 13, Figure 14) antibiotic activity.  
Furthermore, its preservative ability correlates with α-keto-
carboxylate groups in a glycuronoglycan (sphagnan) that 
comprises ∼60% of the holocellulose in the Sphagnum 
hyaline cell walls. 
 
 
Figure 36.  Listeria monocytogenes, a bacteria species that is 
inhibited by extracts of the leafy liverwort Porella cordaeana.  
Photo from CDC, through public domain. 
Harris (2009) considered phylogenetic, elevational, 
and latitudinal relationships of the production of flavonoids 
in medicinal mosses.  He was unable to show any 
significant correlation between phylogenetic independent 
contrasts of total phenolic content, number of flavonoids, 
or percent luteolin derivatives.  He furthermore found no 
correlation with elevation or latitude.  He could not rule out 
the possible correlation with fine-scale ecological features, 
and he considered flavonoid variation to reflect recent 
evolution. 
Labbé et al. (2007) tested the thallose liverwort 
Riccardia polyclada for potential pesticidal properties.  
They identified four compounds that contributed to 
lethality in the brine shrimp (Artemia salina; Figure 37).  
Two of the compounds had moderate activity as an 
antifeedant for the African cotton leafworm (Spodoptera 
littoralis; Figure 38).  They also inhibited culture growth of 
the fungal plant pathogen Cladosporium herbarum (Figure 
39). 
 
 
Figure 37.  Artemia salina, a species that is killed by extracts 
from the liverwort Riccardia polyclada.  Photo by Hans 
Hillewaert, through Creative Commons. 
 
Figure 38.  Spodoptera littoralis, a species that is 
discouraged from eating the liverwort Riccardia polyclada by its 
chemical compounds.  Photo from Forestry Images, through 
Creative Commons. 
 
Figure 39.  Cladosporium spp., fungal pathogens that are 
inhibited by extracts from the liverwort Riccardia polyclada.  
Photo from Mold Treatment Centers of America, through Creative 
Commons. 
Antimicrobial Activity 
Our knowledge of antimicrobial activity of bryophytes 
is mostly based on Sphagnum (Figure 13, Figure 14).  
However other bryophytes are now known to have 
antibiotic properties.  Some of these may just be folklore as 
they have not been tested experimentally.  For example, 
Cheng et al. (2008) reported the folk use of Polytrichum to 
treat pneumonia.  And we have already seen that 
Polytrichum commune (Figure 19) is used in a tea for 
treating colds (Gulabani 1974; Beike et al. 2010). 
Nevertheless, antibiotic properties have been 
demonstrated in the laboratory.  Moss activity against 
Gram-positive and Gram-negative bacteria have been 
demonstrated (Basile et al. 1999; Merkuria et al. 2005; Zhu 
et al. 2006).  Asakawa (2007a, b) has demonstrated many 
effects of liverworts. 
Kumar et al. (2007), in their review of classical 
ethnobotanical Indian uses, reported the antibacterial value 
of the mosses Anomodon rostratus (Figure 30), Atrichum 
angustatum (Figure 40), A. undulatum (Figure 41), and 
Hyophila involuta (Figure 42) and the thallose liverworts 
Conocephalum conicum (Figure 10) and Dumortiera 
hirsuta (Figure 15).  These bryophytes reportedly produce 
antibiotics.  The leafy liverwort Radula complanata 
(Figure 24) similarly has antimicrobial properties.  To these 
we can add the antiseptic properties of Frullania tamarisci 
(Figure 43) (Asakawa 2007b; Chandra et al. 2017) and 
antimicrobial activity of Pallavicinia sp. (Figure 27) 
(Azuelo et al. 2011; Chandra et al. 2017). 
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Figure 40.  Atrichum angustatum, a species with 
antibacterial properties.  Photo by Janice Glime. 
 
 
 
Figure 41.  Atrichum undulatum, a species with 
antibacterial properties.  Photo by Brian Eversham, with 
permission. 
 
 
 
Figure 42.  Hyophila involuta, a species with antibacterial 
properties.  Photo by Michael Lüth, with permission. 
 
Figure 43.  Frullania tamarisci, an epiphytic species with 
antiseptic properties, having both allergenic and medicinal 
properties.  Photo by Michael Lüth, with permission. 
Recent tests on the floating thallose liverwort Riccia 
fluitans (Figure 44) from Florida indicated no ability to 
inhibit growth of the tested bacteria [Pseudomonas 
aeruginosa (Figure 45), Staphylococcus aureus (Figure 
25)] or yeast (Candida albicans; Figure 46) (Pates & 
Madsen 1955).  Vashistha et al. (2007) determined the 
antimicrobial activity of three other thallose liverworts.    
They found that water soluble extracts from 
Conocephalum conicum (Figure 10), Marchantia 
polymorpha (Figure 47), and Plagiochasma 
appendiculatum (Figure 48) had no effect on any of the 
pathogens tested [Gram-negative bacteria Escherichia coli 
(Figure 17) and Salmonella typhi (a variant of S. enterica; 
Figure 49)] and fungi Aspergillus niger (Figure 50) and 
yeast Candida albicans (Figure 46).  However, acetone-
soluble extracts of all three bryophyte species were 
inhibitory against the pathogens.  They were more effective 
against the growth of S. typhi than against E. coli.  
Plagiochasma appendiculatum had a strong inhibitory 
effect against A. niger and Conocephalum conicum was 
strongly inhibitory to Candida albicans. 
 
 
Figure 44.  Riccia fluitans, a species that was unable to 
inhibit the growth of several tested bacteria.  Photo by Štĕpán 
Koval, with permission. 
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Figure 45.  Pseudomonas aeruginosa, a species that is not 
inhibited by Riccia fluitans.  Photo by Janice Haney Carr, 
through Creative Commons. 
 
 
Figure 46.  Candida albicans, a yeast species that is inhibited 
by extracts of the liverworts Conocephalum conicum, 
Marchantia polymorpha, and Plagiochasma appendiculatum, 
but not Riccia fluitans.  Photo from Public Health Image Library, 
through public domain. 
 
 
Figure 47.  Marchantia polymorpha subsp. ruderalis.  This 
species had no effect on the fungi or Gram negative bacteria 
tested by Vashistha et al.  Photo by Malcolm Storey, through 
Creative Commons 
 
Figure 48.  Plagiochasma appendiculatum, a species that is 
effective against some pathogens.  Photo by Ying Jia-dong, 
through Creative Commons. 
 
Figure 49.  Salmonella enterica invading human cells.  
Photo by NIAID, through public domain. 
 
Figure 50.  Aspergillus niger, a fungal species that is 
inhibited by extracts of the liverworts Conocephalum conicum, 
Marchantia polymorpha, and Plagiochasma appendiculatum.  
Photo from Public Health Image Library, through public domain. 
Bukvicki et al. (2012), using solid-phase 
microextraction-gas chromatography mass spectrometry, 
explored the volatile components of the leafy liverwort 
Porella cordaeana (Figure 51).  Using methanol, ethanol, 
and ethyl acetate to extract terpenoids, they were able to 
identify sesquiterpene hydrocarbons and monoterpene 
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hydrocarbons.  These same hydrocarbons were active 
against the eleven food microorganisms tested, but at 
different concentrations among the microorganisms.  The 
fungi among these will be discussed blow.  Affected 
bacterial strains were Salmonella enteritidis (food 
poisoning that causes diarrhea, fever, and abdominal 
cramps; Figure 52), Escherichia coli (commonly found in 
lower intestine of warm-blooded organisms with some 
strains causing food poisoning; Figure 17), and Listeria 
monocytogenes (very virulent food pathogen that causes the 
infection listeriosis; Figure 36).  Methanol extracts showed 
the best activity. 
 
 
 
Figure 51.  Porella cordaeana, a species that is able to 
inhibit a variety of yeasts and bacteria.  Photo by J. C. Schou, with 
permission. 
 
 
Figure 52.  Salmonella enteritidis, a bacteria species that is 
inhibited by extracts of  Porella cordaeana.  Photo through OGL 
(public domain). 
It appears that differences in bryophyte extract activity 
among various pathogens may be common.  Extracts of the 
liverworts Marchantia polymorpha (Figure 47), Porella 
platyphylla (Figure 29), and the moss Dicranum 
scoparium (Figure 16) showed antimicrobial effects on the 
Gram-positive bacteria Bacillus subtilis (Figure 53), 
Staphylococcus aureus (Figure 25), and Micrococcus luteus 
(Figure 54) (Pavletic & Stilinovic 1963; Frahm 2004).  
These same bryophytes exhibited no activity against Gram-
negative Escherichia coli (Figure 17). 
 
Figure 53.  SEM of Bacillus subtilis, a species that is 
inhibited by extracts of several bryophyte species.  Photo by 
Davehwng, through Creative Commons. 
 
Figure 54.  Micrococcus luteus, a bacteria species that is 
inhibited by extracts of several bryophyte species.  Photo by 
Janice Carr, through public domain. 
Basile et al. (1999) isolated seven pure flavonoids 
from five species of mosses.  Some of these exhibited 
strong antibacterial effects against the bacteria 
Enterobacter cloaceae (Figure 55), E. aerogenes (Figure 
56), and Pseudomonas aeruginosa (Figure 45).  They were 
mainly active against Gram-negative bacteria that caused 
severe opportunistic infections and were at the same time 
resistant to commonly used antibacterial therapy.  This 
means that the bryophyte products could become important 
tools in treating some bacterial infections. 
 
 
Figure 55.  Enterobacter cloaceae, a species that is active 
against Gram-negative bacteria.  Photo by Nathan Reading, 
through Creative Commons. 
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Figure 56.  Enterobacter aerogenes, a species that is active 
against Gram-negative bacteria.  Photo by Riraq25, through 
Creative Commons. 
Ariyo et al. (2011) compared the efficacy of extracts 
from the Nigerian thallose liverwort Riccia nigerica as 
antimicrobial agents.  These extracts were tested against the 
bacteria Bacillus subtilis (Figure 53), Pseudomonas 
aeruginosa (Figure 45), Shigella dysenteriae (Figure 57), 
and Staphylococcus aureus (Figure 25) and fungi Rhizopus 
spp. (Figure 58), Aspergillus flavus (Figure 59), A. niger 
(Figure 50), Penicillium spp. (Figure 34), and and 
demonstrated strong significant antibacterial and antifungal 
activity. 
 
 
Figure 57.  Shigella dysenteriae, a bacterial species that is 
inhibited by extracts of Riccia nigerica.  Photo by Public Health 
Image Library, through public domain. 
 
Figure 58.  Rhizopus on yam, a fungal species that is 
inhibited by extracts of Riccia nigerica.  Photo by Charles 
Averre, through Creative Commons. 
 
Figure 59.  Aspergillus flavus, a fungal species that is 
inhibited by extracts of Riccia nigerica.  Photo by Medmyco, 
through Creative Commons. 
The leafy liverwort Ptilidium pulcherrimum (Figure 
60) exhibits antimocrobial activity against both Gram + 
bacteria and Gram negative bacteria, but the effect is 
greater on the Gram positive bacteria (Veljić et al. 2010). 
 
 
Figure 60.  Ptilidium pulcherrimum, a species that is 
effective against both Gram positive and Gram negative bacteria.  
Photo by Hermann Schachner, through Creative Commons 
Antifungal Activity 
Although mosses are known to harbor fungi and will 
quickly become infected if kept moist in a plastic bag, 
some fungi are inhibited by many species of bryophytes, 
including many that cause skin infections.  Jennings (1926) 
reported moss immunity to molds as early as 1926, but the 
possibility of using them as a source of antifungal activity 
seems to have been largely overlooked.  Among these, the 
cosmopolitan moss Hypnum cupressiforme (Figure 61) 
has remarkable antibacterial and antifungal effects.  Ven 
Hoof et al. (1981) demonstrated strong antibacterial and 
antifungal effects by extracts of Hypnum cupressiforme. 
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Figure 61.  Hypnum cupressiforme, a species that is 
effective against fungi that cause skin infections.  Photo by 
Michael Lüth. 
Kumar et al. (2007) report antifungal properties for the 
widespread leafy liverwort Porella platyphylla (Figure 29).  
Ando and Matsuo (1984) demonstrated antifungal effects 
of bryophytes on human pathogenic fungi, but they warned 
that while the bryophyte extracts have fungicidal and 
antifeedant effects, they also may cause allergic reactions 
and dermatitis for some humans. 
Bukvicki et al. (2012), using solid-phase 
microextraction-gas chromatography mass spectrometry, 
explored the volatile components of the related liverwort 
Porella cordaeana (Figure 51).  Using methanol, ethanol, 
and ethyl acetate to extract terpenoids, they were able to 
identify sesquiterpene hydrocarbons and monoterpene 
hydrocarbons.  These same hydrocarbons were active 
against the eleven food microorganisms tested, but at 
different concentrations among the microorganisms.  These 
included the yeasts Saccharomyces cerevisiae (yeast used 
in wine making, baking, and brewing, but antibodies 
against S. cerevisiae are found in 60-70% of patients with 
Crohn's disease; Figure 62), Zygosaccharomyces bailii 
(species causing significant spoilage in the food industry; 
Figure 63), Aureobasidium pullulans (an inhabitant 
of humidifiers or air conditioners that can lead to 
hypersensitivity pneumonitis; Figure 64), Pichia 
membranifaciens (species causing grey mold of fruits; 
Figure 65) (2 strains), Pichia anomala (used in 
winemaking) (2 strains), and Yarrowia lipolytica (used in 
industrial microbiology for production of specialty lipids).  
Methanol extracts showed the best activity. 
 
 
Figure 62.  Saccharomyces cerevisiae SEM, a yeast species 
that is inhibited by extracts of the leafy liverwort Porella 
cordaeana.  Photo by Mogana Das Murtey and Patchamuthu 
Ramasamy, through Creative Commons. 
 
Figure 63.  Zygosaccharomyces bailii, a yeast species that is 
inhibited by extracts of  Porella cordaeana.  Photo by DTDT, 
through Creative Commons. 
 
 
 
Figure 64.  Aureobasidium pullulans, a yeast species that is 
inhibited by extracts of the leafy liverwort Porella cordaeana.  
Photo by Tom Volk, through Creative Commons. 
 
 
 
Figure 65.  Pichia membranaefaciens, a yeast species that is 
inhibited by extracts of  Porella cordaeana.  Photo by Luciana 
Francisco Fleuri & Hélia Harumi Sato, through Creative 
Commons. 
 
The leafy liverwort Ptilidium pulcherrimum (Figure 
60) is not only effective against bacteria, but also against 
fungi (Veljić et al. 2010).  Its best antifungal activity was 
against Trichoderma viride (Figure 66), compared to the 
activity of the synthetic bifonazol. 
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Figure 66.  Trichoderma viride conidiophores, a fungal 
species that is inhibited by Atrichum undulatum, Physcomitrella 
patens, and Marchantia polymorpha.  Photo by Ninjatacoshell, 
through Creative Commons. 
The absence of fungal diseases in liverworts led Pryce 
(1972) to suggest that lunularic acid, a hormone that 
affects aging in liverworts but not in mosses, might be 
responsible for liverwort antifungal activity.  Banerjee and 
Sen (1979; Bannerjee 1974) found that the degree of 
antibiotic activity in a given species may depend on the age 
of the gametophyte; Matsuo et al. (1982a, 1982b, 1983) 
supported this conclusion by demonstrating that antifungal 
activity against Botrytis cinerea (Figure 67), Pythium 
debaryanum (Figure 68), and Rhizoctonia solani (Figure 
69) by the liverwort Herbertus aduncus (Figure 70) was 
age-dependent.  They subsequently isolated three aging 
substances from it:  (-)-alpha-herbertenol; (-)-Beta-
herbertenol, and (-)-alpha-formylherbertenol. 
 
 
Figure 67.  Botrytis cinerea on grapes.  The liverwort 
Herbertus aduncus can exercise antifungal activity against this 
fungus, but activity is age-dependent.  Photo by Alexandre 
Dulaunoy, through Creative Commons. 
 
Figure 68.  Pythium sp.  The liverwort Herbertus aduncus 
can exercise antifungal activity against this fungus, but activity is 
age-dependent.  Photo by Josef Reischig, through Creative 
Commons. 
 
Figure 69.  Rhizoctonia solani infecting leaves.   The 
liverwort Herbertus aduncus can exercise antifungal activity 
against this fungus, but activity is age-dependent.  Photo by 
Howard F. Schwartz, through Creative Commons. 
 
 
Figure 70.  Herbertus aduncus, a leafy liverwort that can 
exercise antifungal activity against several fungi, but activity is 
age-dependent.  Photo by Martin Hutten, with permission. 
Vashistha et al. (2007) determined the antimicrobial 
activity for the thallose liverworts Plagiochasma 
appendiculatum (Figure 48), Marchantia polymorpha 
(Figure 47), and Conocephalum conicum (Figure 10).  
Acetone-soluble extracts of all three bryophyte species 
2-2-16  Chapter 2-2:  Medical Uses:  Biologically Active Substances 
were inhibitory against the fungal pathogens tested.  
Plagiochasma appendiculatum had a strong inhibitory 
effect against Aspergillus. niger and C. conicum was 
strongly inhibitory to Candida albicans.  When Niu et al. 
(2006) tested Marchantia polymorpha (Figure 47) for 
antifungal activities against the yeast Candida albicans 
(Figure 46), they found plagiochin E, 13,13'-O-
isoproylidenericcardin D, and neomarchantin A were active 
against the yeast.  The other identified compounds had only 
weak effects. 
Sabovljević et al. (2011) used DMSO extracts of both 
cultured and wild grown mosses Atrichum undulatum 
(Figure 20) and Physcomitrella patens (Figure 71-Figure 
72) and thallose liverwort Marchantia polymorpha ssp. 
ruderalis (Figure 47) to test for antifungal activity.  Using 
Aspergillus versicolor (Figure 73), Aspergillus fumigatus 
(Figure 74), Penicillium funiculosum (see Figure 34), 
Penicillium ochrochloron, and Trichoderma viride (Figure 
66), these researchers demonstrated antifungal activity by 
all three bryophytes against all five fungal species.  Most of 
the bryophytes grown in culture had greater antibiotic 
activity than the wild-grown ones. 
 
 
Figure 71.  Physcomitrella patens growing on agar plates.  
Photo by Sabisteb, through Creative Commons. 
 
 
Figure 72.  Physcomitrella patens, a source of human 
proteins and blood-clotting factor IX.  Photo by Michael Lüth. 
 
Figure 73.  Aspergillus versicolor, a fungal species that is 
inhibited by Atrichum undulatum, Physcomitrella patens, and 
Marchantia polymorpha.  Photo by James Scott, through 
Creative Commons. 
 
 
 
Figure 74.  Aspergillus fumigatus, a fungal species that is 
inhibited by Atrichum undulatum, Physcomitrella patens, and 
Marchantia polymorpha.  Photo through Creative Commons. 
Alcoholic extracts of all twenty bryophytes tested at 
Bonn University had antifungal activity on infected crops 
(Frahm 2004), as demonstrated in a Petri dish (Figure 75).  
Frahm reports curing a fungal infection of the skin with a 
bryophyte extract.  The success was reported in a TV 
magazine and a published book, causing a number of 
people to use the extract for fungal infections, mostly with 
favorable results.  However, Frahm warns that the 
biologically active substances are terpenoids, and these 
may cause allergic effects to some people (Ando & Matsuo 
1984).  One reputedly can cure athlete's foot by walking 
through a peat bog, presumably because of these same 
terpenoids (Frahm 2004). 
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Figure 75.  Bryophytes are known to inhibit growth of some 
kinds of bacteria and fungi.  Left:  Microbes grow uninhibited 
around a disk with only extraction fluid.  Right:  A zone of 
inhibition occurs around the disk with bryophyte extract.  Photo 
by Jan-Peter Frahm. 
One extract has actually been patented to cure fungal 
infections of horses (Frahm 2004).  An industrious horse 
owner was inspired by what he read about the Bonn 
experiments and made a paste of Ceratodon purpureus 
(Figure 76) and Bryum argenteum (Figure 77).  The 
fungus disappeared from the horse in 24 hours!  This same 
extract is also sold as a human foot cream to refresh and 
fight odor.  Unfortunately, the use for curing fungal 
infections cannot be mentioned in advertising because then 
it would require the extensive testing necessary to meet 
medical approval, which might be difficult because it can 
cause allergies and dermatitis in some people.  It also 
works as an antifeedant against slugs.  Unfortunately, to 
date it must be extracted from field-collected material, 
creating conservation concerns. 
 
 
Figure 76.  Ceratodon purpureus, a species was used with 
Bryum argenteum and killed a fungal infection on a horse.  Photo 
by Janice Glime. 
It appears that some bryophytes may contribute to 
antifungal compounds by hosting a fungus that 
manufactures both antifungal and antitumor compounds 
(Guo et al. 2008).  The leafy liverwort Scapania verrucosa 
hosts the fungus Chaetomium fusiforme (Figure 78).  Not 
only does the latter produce both antifungal and antitumor 
compounds, but the liverwort itself likewise produces them.  
However, the fungus compounds provide superior 
properties and the liverwort might contribute to the 
medicinal field through this fungal endophyte (organisms 
growing within cells of plant, ranging from symbiotic to 
parasitic). 
 
 
Figure 77.  Bryum argenteum, a species that was used in a 
paste with Ceratodon purpureus and killed a fungal infection on 
a horse.  Photo by Martin Hutten, with permission. 
 
 
Figure 78.  Chaetomium globosum.  The fungus 
Chaetomium fusiforme occurs on Scapania verrucosa and 
produces both antifungal and antitumor compounds.  Photo by 
Ulitca, through Creative Commons. 
Antiviral Activity 
Even viruses may some day be cured by extracts of 
mosses, but we cannot simply identify them as "moss" as 
many of our ecologist friends have been wanton to do in 
reporting the ground cover.  The Maoris of New Zealand 
have used bryophytes to treat venereal disease by packing 
wet plants on the infected organs (Frahm 2004).  
Nevertheless, van Hoof and coworkers (1981) found no 
effect of 20 species of moss extracts on the herpes virus, 
but earlier Klöcking et al. (1976) found that at least some 
peat humic acids possess antiviral activity against herpes 
simplex virus types 1 and 2, interfering primarily with the 
adsorption of viruses to host cells.   
Sphagnum (Figure 13, Figure 14) produces several 
antivirally active humic acids, and Camptothecium (Figure 
79) extracts can inhibit growth of the poliovirus (Witthauer 
et al. 1976; van Hoof et al. 1981).  Nevertheless, actual 
usage of bryophytic extracts has not developed outside of 
Asia. 
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Figure 79.  Camptothecium lutescens, in a genus that can 
inhibit growth of the poliovirus.  Photo by David T. Holyoak, 
with permission. 
Cancer and Anti-tumor Properties 
In the same year as the Madsen and Pates (1952) report 
of antibiotics in bryophytes, Belkin et al. (1952-53) 
reported anticancer activity against Sarcoma 37 in mice, 
using extracts of Polytrichum juniperinum (Figure 80).    
But application of the antitumor activity fared no better and 
was apparently not rediscovered in bryophytes until the 
next century.  Finally, Anterola et al. (2009) considered the 
anticancer drug precursors in mosses to be so important 
that they titled their presentation on them "Turning 
precursors into gold:  Production of anticancer drug 
precursors in moss." 
 
 
Figure 80.  Polytrichum juniperinum with antheridial splash 
cups, a species that produces anticancer compounds.  Photo by 
Paul Slichter, with permission. 
Fu et al. (2009) attempted to show anti-cancer 
capabilities of the moss Polytrichum commune (Figure 
19).  To this end, they isolated two "unusual" flavones and 
other compounds from this moss.  However, when tested 
against a small panel of cancer cell lines, they failed to find 
any activity. 
Kumar et al. (2007) found that Indians have used 
Polytrichum juniperinum (Figure 80) to treat cancer.  The 
anti-tumor use of bryophytes in India included 
Chiloscyphus polyanthos (Figure 81), Diplophyllum 
albicans  (Figure 82), D. taxifolium (Figure 85), 
Marchantia palmata, and M. polymorpha (Figure 47).  
Frullania tamarisci (Figure 43) is used as an antileukemic 
agent.  To this list, others added Riccardia sp. (Figure 84) 
(Azuelo et al. 2011; Alam 2012; Chandra et al. 2017) and 
Plagiochila sp. (Figure 11) (Asakawa 2007; Alam 2012; 
Chandra et al. 2017). 
 
 
 
Figure 81.  Chiloscyphus polyanthos, a species that may 
cause allergic reactions.  Photo by Barry Stewart, with 
permission. 
 
 
Figure 82.  Diplophyllum albicans, used as an anti-tumor 
treatment in India and as an agent against epidermoid carcinoma.  
Photo by Michael Lüth, with permission. 
Asakawa (1981) has shown that several compounds 
from leafy liverworts exhibit antileukemic activity.  From 
the thallose species, Marchantin A from Marchantia 
palacea (Figure 83), M. polymorpha (Figure 47), and M. 
emarginata subsp. tosana (Figure 33), riccardin from 
Riccardia multifida (Figure 84), and perrottetin E from 
Radula perrottetii all show cytotoxicity against the 
leukemic KB cells (Asakawa et al. 1982).   
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Figure 83.  Marchantia paleacea, a thallose liverwort known 
for its antileukemic activity.  Photo by Jan-Peter Frahm, with 
permission. 
 
 
Figure 84.  Riccardia multifida, a thallose liverwort known 
for its antileukemic activity.  Photo by Michael Lüth, with 
permission. 
In 1976, Adamek reported that peat preparations hold 
some promise against some types of human cancer.  In 
1977, Ohta and coworkers (1977) reported that 
diplophyllin, isolated from the liverworts Diplophyllum 
albicans (Figure 82) and D. taxifolium (Figure 85), shows 
significant activity (ED50 4-16 µg/ml) against human 
epidermoid carcinoma (KB cell culture). 
 
 
Figure 85.  Diplophyllum taxifolium, a species that produces 
diplophyllin, a compound that is active against human epidermoid 
carcinoma.  Photo by Hermann Schachner, through Creative 
Commons. 
Hughes and Anterola (2010) attempted to transplant 
genes for producing Taxol (a potent anticancer agent) into 
the moss Physcomitrella patens (Figure 71, Figure 72).  
They found evidence of small amounts of the anticancer 
precursors in the moss.  If the moss can be taught 
(genetically) to produce Taxol, it could become a 
laboratory means to manufacture this important anti-cancer 
drug without destroying the diminishing number of Taxus 
(Figure 86) shrubs that produce it naturally.  Bryophytes 
are ideal organisms for such gene transplants because of 
their dominant state with a single set of chromosomes and 
the relative ease with which genes can be put into them. 
 
 
Figure 86.  Taxus baccata, member of the genus that 
produces the anticancer agent Taxol.  Photo through Creative 
Commons. 
When Asakawa (1981, 1982) entered the arena, he 
isolated the sesquiterpenoids costunolide and tulipinolide 
from Conocephalum supradecompositum, Frullania 
monocera, F. tamarisci (Figure 43), Marchantia 
polymorpha (Figure 47), Wiesnerella denudata (Figure 87) 
and Porella japonica (Figure 88).  To this list, Matsuo and 
coworkers (1980, 1981a, b, c, 1984) added Lepidozia vitrea 
(Figure 89) and Plagiochila semidecurrens (Figure 90).  
These substances, already known from higher plants, have 
activity to combat carcinoma of the nasopharynx, at least in 
cell culture. 
 
 
Figure 87.  Wiesnerella denudata, a species that produces 
sesquiterpenoids that are likely to have antibiotic properties.  
Photo by Ying Jia-dong, through Creative Commons. 
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Figure 88.  Porella japonica, a species that produces 
compounds that combat carcinoma of the nasopharynx.  Photo  
from Taiwan mosses color illustrations, through Creative 
Commons. 
 
 
 
 
 
 
Figure 89.  Lepidozia vitrea, a species that produces 
compounds that combat carcinoma of the nasopharynx.  Photo by 
Lin Shanxiong, through Creative Commons. 
 
Figure 90.  Plagiochila semidecurrens, a species that 
produces compounds that combat carcinoma of the nasopharynx.  
Photo by Martin Hutten, with permission. 
When the National Cancer Institute became interested, 
Spjut and his coworkers (1986) tested 184 species of 
mosses and 23 species of liverworts for antitumor activity.  
Of these, 43 species contained active substances, while 
those of 75 species were toxic to tested mice.  The most 
activity was found in Brachytheciaceae (Figure 91), 
Dicranaceae (Figure 16), Grimmiaceae (Figure 92), 
Hypnaceae (Figure 61), Mniaceae (Figure 18, Figure 31), 
Neckeraceae (Figure 2), Polytrichaceae (Figure 19, 
Figure 80), and Thuidiaceae (Figure 93).  However, in 
1988, doubt was cast on the role of the moss when this 
team reported that the antitumor activity of the moss 
Claopodium crispifolium (Figure 94) was greatest in 
samples contaminated with the Cyanobacterium Nostoc cf. 
microscopicum (Figure 95), suggesting that Nostoc could 
be the direct source of the activity or a necessary partner 
for interaction between the species (Spjut et al. 1988).  
Interaction could result from the transfer of a precursor 
from the Nostoc to the moss, which could then transform it 
into an active substance.  Alternatively, the moss might 
produce the substance as an allelopathic response to the 
Nostoc.  In any event, this raises important and intriguing 
questions, both medically and ecologically. 
 
 
Figure 91.  Brachythecium salebrosum (Brachytheciaceae).  
Some members of this family exhibit high antitumor activity.  
Photo by Hermann Schachner, through Creative Commons. 
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Figure 92.  Grimmia nutans (Grimmiaceae).  Some 
members of this family exhibit high antitumor activity.  Photo by 
Michael Lüth, with permission. 
 
 
Figure 93.  Thuidium tamariscinum (Thuidiaceae).  Some 
members of this family exhibit high antitumor activity.  Photo by 
Malcolm Storey (DiscoverLife.com), with online permission. 
 
 
Figure 94.  Claopodium crispifolium, a moss that provides 
habitat for Nostoc, which in turn has anti-tumor properties.  Photo 
from Botany Website, UBC, with permission. 
 
Figure 95.  Nostoc sp., a moss contaminant that can increase 
anti-tumor activity.  Photo from Retina, through Creative 
Commons. 
For some reason, much of the biochemical work has 
concentrated on the liverworts.  Similar studies on activities 
of moss compounds are sparse and there may be good 
reason to presume a greater medical treasure chest among 
the liverworts.  Since these compounds generally benefit 
the bryophytes by discouraging their would-be herbivores, 
it is the tiny, slow-growing liverworts that stand to benefit 
most.  Where other, larger plants have spent their 
evolutionary history developing a diversity of structure, it 
would seem that small size has afforded these plants only 
the benefits of diversity of biochemistry as a means of 
combating the hungry herbivores. 
Burgess et al. (2000) found that the leafy liverwort 
Bazzania novae-zelandiae (Figure 96) produces a 
sesquiterpene caffeate that has selective activity against 
certain human tumor cells.  The active compound has been 
identified as the new compound naviculyl caffeate. 
  
 
Figure 96.  Bazzania novae-zealandiae, a species that is 
active against human tumor cells.  Photo by Shirley Kerr, with 
permission. 
Even breast cancer sufferers might benefit from 
bryophytes.  Huang et al. (2010) found that marchantin A 
produced by Marchantia emarginata subsp. tosana 
(Figure 33) induced apoptosis in MCF-7 breast cancer 
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cells.  This compound demonstrates strong antioxidant 
activity, scavenging free radicals.   
The leafy liverwort Scapania verrucosa and its 
endophytic fungal inhabitant Chaetomium fusiforme (see 
Figure 78) produce several compounds that act as 
antitumor agents (Guo et al. 2008). 
The thallose liverwort Dumortiera hirsuta (Figure 15) 
produces riccardin D, a macrocyclic bisbibenzyl 
compound that induces apoptosis of human leukemia cells 
(Xue et al. 2012).  Xue and coworkers verified anticancer 
activity by riccardin D against human non-small cell lung 
cancer.  In mice it produced a 44.5% inhibition of cancer 
growth with no apparent toxicity. 
Pharmaceutical Production 
Welcome to Greenovation!  Moss for a healthy future.  
So began the website <http://www.greenovation.com/> of 
an upstart company that is growing the tiny Physcomitrella 
patens (Figure 71, Figure 72) for medicinal purposes.  Yes, 
bryophytes have indeed finally penetrated the forefront of 
modern medicine! 
Physcomitrella patens (Figure 71, Figure 72) is able to 
accept transferred human genes and express them to 
produce human antibodies in a liquid culture, making the 
antibodies easy to harvest (ETH Zurich 2009).  So far, this 
is not possible when the genes are transplanted into "higher' 
organisms.  One advantage of Physcomitrella patens is its 
ability to grow in a "bioreactor" (Figure 97; Decker & 
Reski 2004), a fermenter in which only water and minerals 
are needed to nourish the moss, of course in the presence of 
light and CO2 (Greenovation).  These tiny plants are actually superior (and cheaper) production systems for 
many complex recombinant pharmaceuticals (Bauer et al. 
2005; Decker & Reski 2007, 2012; Gitzinger et al. 2009).  
Contrary to many mammalian systems that have been used 
to produce pharmaceuticals but that cause serious immune 
responses, those produced by Physcomitrella patens are 
non-immunogenic, a huge advantage for the patient, and 
making them superior to currently used mammalian cell 
lines for producing antibodies. 
Among its many assets, Physcomitrella patens (Figure 
71, Figure 72) is able to produce human proteins (Hohe et 
al. 2002; Decker et al. 2003) and is the only plant being 
used to produce the blood-clotting factor IX for 
pharmaceutical use.  This discovery, patented by Prof. 
Reski of the Institute of Biotechnology of Plants at the 
University of Freiburg in Germany, led to the founding of 
the Greenovation Company in 1999.  By 2002, the 
company was already employing 30 people to produce this 
valuable blood factor (Frahm, Bryonet discussion 2002). 
Bryophytes offer the researchers, and the company, a 
number of advantages over "higher" plants.  They can be 
grown without antibiotics, hence avoiding the danger of 
contamination of the final product.  The moss is quite small 
and thus is cultured only in the lab with little danger of the 
transgenic plants escaping into the environment.  But the 
real advantage comes from the dominant gametophytic 
generation of mosses as opposed to the dominant 
sporophyte of the tracheophytes.  As a result, mosses are 
the only plants known to have a high frequency of 
homologous recombination.  The result – stable integration 
of inserted genes into the genome.  Furthermore, the highly 
complex moss system, compared to bacteria and fungi, 
permits a much wider array of expression than is possible 
in those systems.  Thus, mosses are extremely useful as 
production systems for targeted substances that can be 
produced through gene manipulation. 
 
 
 
Figure 97.  This type of bioreactor is used to grow 
Physcomitrella patens for human proteins and human blood-
clotting factor IX.  Photo by Ralf Reski.  
 
 
Unfortunately, most biologically active substances so 
far obtained have not proved economical for use, at least in 
part due to the slow-growing nature and difficulty of 
culturing bryophytes.  And, while their pharmaceutical use 
seems promising, we lack any understanding of their 
potential harmful side effects.  
In the words of Ma et al. (2003), "Imagine a world in 
which any protein, either naturally occurring or designed 
by man, could be produced safely, inexpensively and in 
almost unlimited quantities using only simple nutrients, 
water and sunlight. This could one day become reality as 
we learn to harness the power of plants for the production 
of recombinant proteins on an agricultural scale. Molecular 
farming in plants has already proven to be a successful way 
of producing a range of technical proteins. The first plant-
derived recombinant pharmaceutical proteins are now 
approaching commercial approval, and many more are 
expected to follow." 
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Medical Dangers 
Caution is in order in exercising any medicinal use of 
bryophytes, particularly liverworts, because of their 
potential for causing allergic reactions (Mitchell et al. 
1969, 1970; Benezra et al. 1985, Asakawa 2012).  Often 
the very compounds that have these medical potentials can 
cause allergic reactions.  For example, it is a sesquiterpene 
lactone (Asakawa 1981) that gives the common epiphyte 
Frullania (Figure 98-Figure 99) its ability to cause contact 
dermatitis, especially to forest workers (Mitchell et al. 
1969).  Now there is a patch test with a sesquiterpene 
lactone mix to determine sensitivity to Frullania (Quirce et 
al. 1994). 
Yet sesquiterpene lactones are well known for their 
antimicrobial activity.  In southern Europe, Frullania 
tamarisci (Figure 43, Figure 98) imparts an allergic 
reaction to olive pickers, yet is listed as one of the 
medicinal species (J. Curnow, pers. comm.).  D. H. Wagner 
(pers. comm.) reports an allergy to Chiloscyphus 
polyanthos (Figure 81), especially when he squeezes it to 
remove excess water.  By 1981, 24 liverwort species were 
known to have potential allergenic sesquiterpene lactones 
(Asakawa 1981).  These compounds undoubtedly endow 
the same advantage to bryophytes that they do to flowering 
plants – discouraging consumption by hungry herbivores.   
 
 
 
Figure 98.  Frullania tamarisci, showing underside of 
branch with lobules by which the genus may be determined.  
Photo by Michael Lüth, with permission. 
 
Frullania tamarisci (Figure 43, Figure 98) grows on 
trees and can cause skin irritations for loggers and even for 
their wives who handle their clothes.  Allergic reactions to 
Frullania nisquallensis (Figure 99) occurred in patch tests 
on seven forest workers who had contact dermatitis 
(Mitchell et al. 1969).  These forest workers exhibited the 
dermatitis only when they were working on forest areas.  
The problem was worse in wet weather and appeared 
within 1-2 days of starting work.  The condition persisted 
for 2-4 weeks after leaving work in forested areas where 
the liverwort grew.  The condition is often known locally in 
British Columbia, Canada, as cedar poisoning, but in fact it 
is caused by the liverworts that commonly grow on the 
cedars (Thuja; Figure 100). 
 
 
Figure 99.  Frullania nisquallensis, a leafy liverwort 
epiphyte that causes allergic reactions among forest workers.  
Photo by Dale Vitt, with permission. 
 
Figure 100.  Thuja plicata, host plant for Frullania species.  
Photo from <www.nwplants.com>, through Creative Commons. 
  
Summary 
Bryophytes, especially liverworts, often have 
distinct odors, suggesting aromatic compounds such as 
phenols.  However, few bryophytes have been linked to 
actual curative properties and identifiable associated 
compounds. 
One danger in using bryophytes is that the same 
compounds that may have antibiotic properties may 
also be toxic or allergenic, or be associated with such 
compounds.  Furthermore, peatland mosses may have 
associated fungi that cause sporotrichosis. 
Many antibiotics have been isolated from 
bryophytes, but few have been developed for medical 
use, despite their demonstrated effectiveness.  In 
Germany, Ceratodon purpureus and Bryum 
argenteum are used to cure fungal infections of horses.  
Several medical uses seem promising, such as 
antileukemic properties and anticancer agents. 
The most promising uses of bryophytes in 
medicine seem to lie in genetic engineering.  
Bryophytes are being used already to produce human 
blood-clotting proteins, while others are known to 
reduce thrombin activity.  
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